I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Manda, Sudhir
31
results:
Search for persons
X
Format
Online (31)
Mediatypes
Articles (Online) (22)
Bookchapter (Online) (1)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
A phase 3b study of venetoclax and azacitidine or decitabin..:
Manda, Sudhir
;
Anz III, Bertrand M.
;
Benton, Christopher
...
Hematological Oncology. 42 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1002/..
?
2
Genomic landscape of patients in a phase II study of zanubr..:
Xu, Linlin
;
Shadman, Mazyar
;
Flinn, Ian W.
...
Haematologica. , 2024
Link:
https://doi.org/10.3324/..
?
3
In-class transition (iCT) of proteasome inhibitor-based the..:
Rifkin, Robert M.
;
Girnius, Saulius K.
;
Noga, Stephen J.
...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO O..:
Girnius, Saulius K.
;
Richter, Joshua
;
Lyons, Roger M.
...
HemaSphere. 7 (2023) S3 - p. e149880d , 2023
Link:
https://doi.org/10.1097/..
?
5
P-114 In-class transition (iCT) from parenteral bortezomib ..:
Girnius, Saulius
;
Richter, Joshua
;
Lyons, Roger
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S97-S98 , 2023
Link:
https://doi.org/10.1016/..
?
6
POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bo..:
Girnius, Saulius K.
;
Richter, Joshua
;
Lyons, Roger
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S221 , 2023
Link:
https://doi.org/10.1016/..
?
7
MM-465 In-Class Transition (iCT) from Parenteral Bortezomib..:
Girnius, Saulius K.
;
Richter, Joshua
;
Lyons, Roger
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S501 , 2023
Link:
https://doi.org/10.1016/..
?
8
Poster: MM-253 Efficacy, Safety, and Quality of Life (QoL) ..:
Manda, Sudhir
;
Yimer, Habte A.
;
Birhiray, Ruemu E.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S179 , 2022
Link:
https://doi.org/10.1016/..
?
9
MM-253 Efficacy, Safety, and Quality of Life (QoL) in Patie..:
Manda, Sudhir
;
Yimer, Habte A.
;
Birhiray, Ruemu E.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S416-S417 , 2022
Link:
https://doi.org/10.1016/..
?
10
P-204: In-class transition (iCT) from parenteral bortezomib..:
Yimer, Habte
;
Birhiray, Ruemu
;
Boccia, Ralph
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S147-S148 , 2022
Link:
https://doi.org/10.1016/..
?
11
CLL-076: Phase 3b Study to Evaluate Debulking Regimens Prio..:
Sharman, Jeff
;
Andorsky, David
;
Melear, Jason
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S219-S220 , 2020
Link:
https://doi.org/10.1016/..
?
12
Feasibility of Long-term Proteasome Inhibition in Multiple ..:
Manda, Sudhir
;
Yimer, Habte A.
;
Noga, Stephen J.
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) 11 - p. e910-e925 , 2020
Link:
https://doi.org/10.1016/..
?
13
MM-202: Long-Term Proteasome Inhibition in Multiple Myeloma..:
Birhiray, Ruemu E.
;
Manda, Sudhir
;
Girnius, Saulius K.
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S299 , 2020
Link:
https://doi.org/10.1016/..
?
14
Long-term proteasome inhibition in newly diagnosed multiple..:
Yimer, Habte
;
Rifkin, Robert
;
Noga, Stephen
...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e11 , 2019
Link:
https://doi.org/10.1016/..
?
15
Comorbidities predict inferior outcomes in chronic lymphocy..:
Gordon, Max J.
;
Churnetski, Michael
;
Alqahtani, Hamood
...
Cancer. 124 (2018) 15 - p. 3192-3200 , 2018
Link:
https://doi.org/10.1002/..
1-15